Reliq Health Technologies, Inc. Announces Onboarding of New Mental Health Patients and Management Changes
Reliq Health Technologies, Inc. Announces Onboarding of New Mental Health Patients and Management Changes
HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) ("Reliq" or the "Company"), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.
安大略省漢密爾頓,2024年3月25日(環球新聞專線)——Reliq Health Technologies Inc.(多倫多證券交易所股票代碼:RHT 或 OTC: RQHTF 或 WKN: A2AJTB)(“Reliq” 或 “公司”)是一家正在成長中的全球醫療保健技術公司,爲數十億美元的醫療保健市場開發創新的虛擬護理解決方案,很高興地宣佈,其擴大的心理健康領域將增加首批五百名患者服務組合,預計到2024年底將再增加10,000名患者。
"We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new expanded mental health care program," said Chris Shields, CEO at Reliq Health Technologies, Inc. "Providing cognitive assessments through iUGO Care will allow clinicians to identify and treat patients with previously undiagnosed mental health needs. Eligible patients will be provided with ongoing behavioral health or collaborative care management services, for which their physician will pay Reliq's standard monthly subscription fees. In addition, patients will receive cognitive assessments twice per year for which their physician will pay Reliq a one-time fee per assessment. The Company expects to generate an average revenue of $576 per patient per year or $48 per patient per month for these patients at 70% gross margin, and expects to add a further 10,000 new patients to our expanded mental health care program by the end of 2024. The high demand for our new expanded mental health care services further demonstrates our products' unique ability to address existing unmet needs in the Medicare patient population. Our clients' have consistently expressed high levels of satisfaction with the usability and efficacy of our products, and with the cost savings and new revenue streams they realize by offering new services through our iUGO Care platform."
Reliq Health Technologies, Inc.首席執行官克里斯·希爾茲說:“我們很高興將美屬維爾京群島、佛羅里達州和內華達州的前五百名患者添加到我們新的擴展心理保健計劃中,通過IuGo Care提供認知評估將使臨床醫生能夠識別和治療以前未被診斷的心理健康需求的患者。符合條件的患者將獲得持續的行爲健康或協作護理管理服務,他們的醫生將爲此支付Reliq的標準月度訂閱費。此外,患者每年將接受兩次認知評估,他們的醫生將爲每次評估向Reliq支付一次性費用。該公司預計,毛利率爲70%,平均每年爲每位患者創造576美元的收入或每位患者每月48美元的收入,並預計到2024年底,我們擴大的心理保健計劃將再增加10,000名新患者。對我們新的擴展心理保健服務的高需求進一步表明了我們的產品具有滿足醫療保險患者群體中現有未滿足需求的獨特能力。我們的客戶一直對我們產品的可用性和功效,以及他們通過我們的iuGo Care平台提供新服務而節省的成本和新的收入來源表示高度滿意。”
The Company also wishes to announce that it has accepted the resignation of its Chief Financial Officer, Michael Frankel. Following the resignation of Mr. Frankel, the Board of Directors has appointed Mr. Kevin Cornish as the Company's Chief Financial Officer.
該公司還希望宣佈,它已接受其首席財務官邁克爾·弗蘭克爾的辭職。弗蘭克爾先生辭職後,董事會任命凱文·康沃爾先生爲公司首席財務官。
"We are also delighted to announce the addition of Kevin Cornish to the Reliq Management team as the Company's Chief Financial Officer," continued Mr. Shields. "Mr. Cornish possesses the critical skills and experience that will enable Reliq to continue to grow its business in size and complexity. Mr. Cornish is an accomplished public company CFO with over 17 years of international leadership experience in finance, strategy and operations. He has worked with multiple start-ups and led successful turnarounds at a diverse group of companies in both Canada and the United States. His experience with public company audits and cross-border businesses will be a tremendous asset to Reliq going forward. Mr. Cornish holds an MBA and a CPA designation."
希爾茲繼續說:“我們還很高興地宣佈,凱文·康沃爾加入Reliq管理團隊,擔任公司的首席財務官。”“康沃爾先生擁有關鍵技能和經驗,這將使Reliq能夠繼續擴大其業務的規模和複雜性。康沃爾先生是一位出色的上市公司首席財務官,在財務、戰略和運營方面擁有超過17年的國際領導經驗。他曾與多家初創企業合作,併成功領導了加拿大和美國的多元化公司轉型。他在上市公司審計和跨境業務方面的經驗將成爲Reliq未來的巨大資產。康沃爾先生擁有工商管理碩士學位和註冊會計師稱號。”
About Reliq Health
Reliq Health Technologies is a growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq's powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.
關於 Relq Health
Reliq Health Technologies是一家成長中的全球醫療保健技術公司,專門爲數十億美元的醫療保健市場開發創新的虛擬護理解決方案。Reliq 強大的iuGo Care平台支持護理協調和基於社區的虛擬醫療保健。iuGo Care使複雜的患者能夠在家中獲得高質量的護理,改善健康狀況,提高患者和家屬的生活質量並降低護理成本。iuGo Care提供對遠程患者監測數據的實時訪問,使護理團隊能夠及時進行干預,以防止昂貴的再入院和急診室就診。Reliq Health Technologies在多倫多證券交易所風險投資基金上市,股票代碼爲RHT,在場外交易所上市,股票代碼爲RQHTF,在法蘭克福證券交易所上市,股票代碼爲WKN:A2AJTB。
ON BEHALF OF THE BOARD
"Chris Shields"
Interim CEO
代表董事會
“克里斯·希爾茲”
臨時首席執行官
For further information please contact:
欲了解更多信息,請聯繫:
Company Contact
Investor Relations at ir@reliqhealth.com
公司聯繫人
投資者關係部位於 ir@reliqhealth.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
關於前瞻性信息的警示聲明
根據適用的證券法的規定,本新聞稿中的某些陳述構成前瞻性陳述。所有非歷史事實的陳述,包括但不限於有關未來估計、計劃、計劃、預測、目標、假設、預期或未來業績信念的陳述,均爲 “前瞻性陳述”。
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
我們提醒您,此類 “前瞻性陳述” 涉及已知和未知的風險和不確定性,可能導致實際和未來事件與此類陳述中的預期存在重大差異。
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
前瞻性陳述包括但不限於與商業運營有關的陳述,包括技術開發、預期收入、預計市場規模以及其他基於未來業績預測、尚未確定的金額估計和管理假設的信息。
Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
除非法律要求,否則Reliq Health Technologies Inc.(以下簡稱 “公司”)不打算也不承擔任何義務更新這些前瞻性陳述。這些前瞻性陳述涉及與技術開發和營銷活動、公司在技術開發方面的歷史經驗、未投保風險等相關的風險和不確定性。實際結果可能與此類前瞻性陳述所表達或暗示的結果存在重大差異。
SOURCE: Reliq Health Technologies Inc.
資料來源:Reliq 健康科技公司
譯文內容由第三人軟體翻譯。